Table 4 Change in headache outcomes and behavioural parameters at follow-up (3–6 months, n = 66–69)
From: Pain-related avoidance and endurance behaviour in migraine: an observational study
Baseline | Follow-up (3–6 months) | Statistics | |
|---|---|---|---|
Headache days per month | 12.9 ± 7.9 | 8.5 ± 7.7 | Z = − 5.7, p < 0.001 |
Headache intensity [0–10] | 6.5 ± 1.6 | 6.0 ± 1.7 | Z = − 2.6, p = 0.009 |
Days with intake of acute migraine medication per month | 8.5 ± 5.3 | 6.3 ± 4.7 | Z = − 3.9, p < 0.001 |
MIDAS score [0–270] | 42.2 ± 39.8 | 30.9 ± 39.5 | Z = − 3.0, p = 0.003 |
PDI [0–10] | 4.5 ± 2.2 | 3.9 ± 2.4 | Z = - 2.0, p = 0.048 |
HADS-Depression | 4.9 ± 3.4 | 4.8 ± 3.3 | Z = − 0.5, p = 0.65 |
HADS-Anxiety | 7.5 ± 3.9 | 7.2 ± 3.8 | Z = - 0.5, p = 0.64 |
AEQ-ASAS (Avoidance of social activities) [0–6] | 2.8 ± 1.2 | 2.9 ± 1.2 | Z = − 0.9, p = 0.36 |
AEQ-APAS (Avoidance of physical activities) [0–6] | 3.6 ± 1.0 | 3.7 ± 1.0 | Z = − 1.6, p = 0.12 |
AEQ-BES (Behavioural endurance) [0–6] | 2.9 ± 0.8 | 2.9 ± 0.9 | Z = − 0.3, p = 0.73 |
AEQ-HDS (Humor/distraction) [0–6] | 2.2 ± 0.9 | 2.2 ± 1.0 | Z = − 0.7. p = 0.51 |
AEQ-PPS (Pain persistence) [0–6] | 3.4 ± 0.9 | 3.4 ± 0.9 | Z = − 0.7, p = 0.51 |